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Inter-organ communications: 
with particular reference to hepatotrophic 
factors and intrinsic liver growth factors 
T. E. STARZL. K. A. PORTER and J. TERBLANCHE 
In the natural state, the liver obtains more than three-quarters of its blood 
supply through the portal vein. The possible potential endocrinological 
significance of this circumstance was barely perceived until recently. Now it 
is understood that the gastrointestinal tract is (amongst other things) a com-
plex of endocrine foci which contains and can release a dozen or more bio-
logically active polypeptides 1. 2 into the portal circulation. From there, these 
polypeptides are exposed to the liver on tlrst pass, and thus could, at least 
potentially, influence hepatic structure, function and the capacity for re-
generation. There is no question that this happens. 
PORTAL BLOOD DEPRIVATION AND THE 
NON-REGENERATING LIVER 
When portacaval shunt (Eck fistula) is performed, the liver which now depends 
upon its arterial circulation, undergoes major atrophic changes within 3 or 4 
days 3. Ultrastructurally, the most specific changes are depletion and dis-
ruption of the rough endoplasmic reticulum and reduction in the membrane-
bound ribosomes. In the face of acute atrophy, there is moderate hyperplasia, 
cell renewal being increased about 3 times 3 • It was for a long time thought 
that these changes were caused by the decreased quantity of the total hepatic 
blood flow 4 • However, evidencc which was at first circumstantiaP' 6 and later 
direct 3 has shown that the most important loss was not the volume of portal 
flow but some substance(s) within the portal blood that could not be replaced 
by equal volumcs of systemic blood. 
The single most important ingredient of portal blood proved to be insulin. 
The crucial experiment was exceptionally simple 3 . After complete portacaval 
shunt in dogs, non-hypoglycaemic doses of insulin were infused into the 
tied-off left portal vein. The acute atrophy and ultrastructural deterioration 
normally caused by Eek fistula was greatly reduced in those lobes supplied by 
the left portal vein. There was no spillover effect to the non-infused right liver 
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lobes. An additional effect of the insulin was major hepatocyte hyperplasia 
which was of the magnitude of a regeneration response after hepatectomy. 
Infusions of glucagon alone or added to insulin had no demonstrable effect. 
The striking morphological consequences of portal diversion are accom-
panied by major, although subtle, changes in function. Because they have 
clinical signifieanec, much attention has been paid to the consequent altera-
tions in lipid metabolism. Hepatic cholesterol and triglyceride synthesis are 
markedly diminished by portacaval shunt in animals 7 and humans 8 and there 
is a coi ncidental fall in serum cholesteroF. Many patients with idiopathic 
Type II hyperJipidaemia have now been treated by portacaval shunt, and 
usually with a striking fall of serum cholesterol and low-density lipoprotein 9. 
The complex metabolic changes after portal diversion have also been ex-
ploited as a palliative to patients with glycogen storage disease I o. 
There is the possibility that the liver damage of aI-antitrypsin deficiency 
can be slowed by portacaval shunt. In this disorder, the abnormal aI-anti-
trypsin elaborated by the liver cannot be excreted and thus accumulates in the 
hepatocytes. Two of our paediatric patients have been followed for I! and 3t 
years following portacaval shunt. Both have had stabilization of their pre-
viously deteriorating clinical state. In one, serial liver biopsies have demon-
strated by semi-quantitative organelle analyses a progressivc diminution of the 
(LI-antitrypsin within hepatocytes. Our assumption is that portacaval shunt 
diminished the synthesis of the glycoprotein (presumably by altering the 
rough endoplasmic reticulum and polyribosomes) without commensurately 
reducing the transport of this a-protein. 
PORTAL FACTORS AND LIVER REGENERATION 
We turn now to thc influence of portal blood factors upon hepatic regenera-
tion. It is clear that regeneration cannot proceed normally in the absence of 
non-hepatic splanchnic viscera. But which of the splanchnic organs is the 
touchstone for liver renewal? In dogs submitted to excision of all the non-
hepatic splanchnic organs, no regeneration whatever can be secn, at least 
within the first 2 or 3 days after concomitant partial hepatectomy I I. The loss 
of the pancreas with the evisceration is not the entire explanation. When only 
total pancreatectomy is performed at the time of partial hepatectomy, a 
subdued but easily identifiable regeneration proceeds in the diabetic dogs II. 
The mirror-image procedure in which all the viscera except the pancreas are 
removed also markedly inhibits, but does not abolish, regeneration II. The 
evidence thus suggests that several splanchnic organs contribute multiple 
growth factors, and that the pancreas, albeit important, is far from the only 
source of regenerative factors. 
The essential role of the so-called portal hepatotrophic factors (including 
insulin) in liver regeneration seems indisputable. However, the controversial 
issue is whether these factors merely permit regeneration to go forward, or 
whether changes in these factors actuaJJy initiate regeneration by biochemical 
pathways involving mainly adenyl cyclase activation and deactivation. 
MacManus and his associates of Canada 12 have produced evidence in tissue 
culture systems and after partial hepatectomy in rats which is compatible with 
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cellular growth control by hormone interactions. Early biphasic rises in cyclic 
AMP with a return towards normal as DNA synthesis begins have been con-
firmed in rats 13,14 and in dogs 15. The experiments of Short, Gaza and 
Lieberman 16-18 are also compatible with the hormone control hypothesis. 
However, the hypothesis has not been proved. Attacks on the hormone 
control theory of liver regeneration have been frequent but indecisive. An 
example is a recent paper by Price and his associates' 9. In cross-circulated 
rats, they removed all of the intra-abdominal viscera, including the liver, from 
one animal and observed liver regeneration in the normal partner. Their con-
clusion was that they had disproved the splanchnic initiation of regeneration. 
The experimental design was flawed. Conceptually, what had been performed 
was a technically complicated 50 /~ hepatectomy whereby two animals with 
a shared circulation had half of their combined liver mass removed. The other 
liver half, which was now essentially a fragment with an intact splanchnic 
organ-liver axis, regenerated vigorously. 
INTRINSIC LIVER GROWTH FACTORS 
The issue of portal hepatotrophic control of liver regeneration thus remains 
unsettled. An additional possibility is that something in the liver fragment 
after hepatectomy can contribute to, or even initiate, its own regrowth. Recent 
work from our laboratories 20 and by LaBrecque and Pesch 21 has raised 
interesting questions about this concept. By ultracentrifugation at 140000 g, 
we made canine hepatic cytosol extracts that were free of cell membranes, 
organelles and viruses. Such cytosol contains proteins and other con-
stituents that are soluble, but no insulin and very little glucagon. The cytosol 
was tested in the same Eck fistula model described earlier by injecting it as a 
4-6 h bolus into the tied-off left portal vein, just after completion of a 
portacaval shunt. 
The results were unequivocapo. Cytosol from normal adult livers had no 
effect upon the events that follow Eck fistula, nor did the cytosol prepared 
from liver fragments remaining after 72 % hepatectomy performed I day 
earlier. However, 2-day regenerating liver changed the pattern of results and 
3-day regenerating liver was even more potent. I n the directly infused left liver 
lobes the active cytosol extracts initiated a burst of regeneratiol) which had a 
delayed onset. The increased mitoses were not clearly seen until 2 days after 
the pulse of cytosol had been given, with a response that was doubled again at 
3 days and almost completely confined to the directly treated lobes 22. 
Proliferation was not the only cytosol effect. The atrophy characteristic of 
Eck fistula proceeded for 2 days after the delivery of the active liver extracts, 
but between the second and third days there was a dramatic reversal. Now the 
hepatocytes returned to normal size at the same time as other structural and 
ultrastructural features of these cells were restored to or towards normal 2 o. 
The result at 3 days was a liver in which healthy hepatocytes in the left but 
not the right liver lobes wcre undergoing changes indistinguishable from 
vigorous regeneration. 
The cytosol has been tested in another canine system. Dogs were submitted 
to 44% hepatectomy, a procedure which in otherwise unaltered animals 
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evokes a moderate regeneration. Cytosol from 48 and 72 h regenerating livers 
was given intraportally over a 6 h period to the test dogs immediately after 
completion of their 44 % hepatectomies. The expected regeneration response 
was significantly amplified by the cytosol from regenerating livers. No change 
in the expected response was caused either by cytosol from normal dog liver 
or by a 6 h infusion of intraportal insulin. When given intraportally to normal 
dogs, the active cytosols did not cause any change in the baseline mitotic 
index. 
It seems clear that regenerating livers come to possess some kind of 
stimulatory growth factor. The significance of this growth factor is by no 
means certain, nor is its relationship to the so-called portal hepatotrophic 
factors. Does this stimulatory liver factor merely reflect the fact that regenera-
tion is going on? Is its development dependent upon input of the so-called 
portal hepatotrophic factors? And does it influence regeneration in the liver 
fragment in which it resides? Experiments are in progress to answer such 
questions. However, a real understanding of this liver growth factor will be 
dependent upon its isolation and biochemical characterization. 
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